Literature DB >> 7801810

Actin-bound nucleotide/divalent cation interactions.

L C Gershman1, L A Selden, H J Kinosian, J E Estes.   

Abstract

At this point, it may be worthwhile to list, in summary form, the important aspects of divalent cation and nucleotide binding to actin that have been reviewed here: 1) High affinity divalent cation binding to actin is very tight, with equilibrium dissociation constant KCa approximately 1 nM and KMg approximately 5 nM at pH 7.0. 2) The binding kinetics of Ca++ are diffusion limited. Dissociation is slow, with k-Ca approximately 0.015 sec at pH 7.0 (and low ionic strength). 3) The binding kinetics of Mg++ are limited by the characteristics of the Mg++ aquo-ion and are much slower than for Ca++; k-Mg approximately 0.0012 at pH 7.0. 4) Increase in pH or ionic strength weakens divalent cation binding at the high affinity site, primarily by increasing k-Ca and k-Mg. 5) Exchange of Mg++ for Ca++ (or vice versa) at the high affinity site is by a competitive pseudo-first order process with an apparent rate constant (kapp) intermediate between k-Ca and k-Mg and dependent upon the cation concentration ratio [Ca]/[Mg] present. 6) High affinity ATP binding is modulated by the high affinity divalent cation. The cation concentration range over which this modulation occurs is about 100-fold higher for Mg++ than for Ca++, again because of the different characteristics of the Mg++ and Ca++ aquo-ions. 7) At low divalent cation concentrations, ATP dissociation from actin is limited by dissociation of the tightly-bound divalent cation. 8) At high divalent cation concentrations, ATP dissociation probably occurs via dissociation of the divalent cation-nucleotide complex and is quite slow, with dissociation rate constant approximately 0.0005 sec-1. 9) Competitive nucleotide exchange on actin may be described by a pseudo-first order model analogous to that for divalent cation exchange. The pseudo-first order rate constants depend upon the divalent cation concentration. The overall nucleotide exchange rate constant kex depends upon these constants and the solution nucleotide concentration ratio, e.g. [ATP]/[ADP]. The following circumstances develop from the characteristics of the high affinity binding of divalent cation and nucleotide to actin: 1) The standard methods for actin preparation convert in vivo Mg-actin into Ca-actin. 2) Converting Ca-actin back to Mg-actin is not easy. A very low ratio of [Ca]/[Mg] is necessary, which usually requires the use of Ca-cheltors, and a long time (5-10 min) must be allowed for complete exchange.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7801810     DOI: 10.1007/978-1-4615-2578-3_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Solution properties of tetramethylrhodamine-modified G-actin.

Authors:  Dmitry S Kudryashov; Emil Reisler
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

2.  Differential regulation of actin polymerization and structure by yeast formin isoforms.

Authors:  Kuo-Kuang Wen; Peter A Rubenstein
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

3.  Mechanical properties of actin filament networks depend on preparation, polymerization conditions, and storage of actin monomers.

Authors:  J Xu; W H Schwarz; J A Käs; T P Stossel; P A Janmey; T D Pollard
Journal:  Biophys J       Date:  1998-05       Impact factor: 4.033

4.  Water in actin polymerization.

Authors:  N Fuller; R P Rand
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

5.  Ca2+ bound to the high affinity divalent cation-binding site of actin enhances actophorin-induced depolymerization of muscle F-actin but inhibits actophorin-induced depolymerization of Acanthamoeba F-actin.

Authors:  M Mossakowska; E D Korn
Journal:  J Muscle Res Cell Motil       Date:  1996-08       Impact factor: 2.698

6.  ATP and ADP actin states.

Authors:  Dmitri S Kudryashov; Emil Reisler
Journal:  Biopolymers       Date:  2013-04       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.